Furthermore, TRIM28 expression was significantly correlated with pathological stage (Figure 1C), and TRIM28 expression in metastatic BRCA, PRAD, COAD, LIHC, SKCM, and OV tumors was higher than that in the corresponding primary tumors (Figure 1D). The gene discussed is TRIM28; the disease is prostate adenocarcinoma.